98 related articles for article (PubMed ID: 8473789)
21. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
Leong HS; Mahesh BM; Day JR; Smith JD; McCormack AD; Ghimire G; Podor TJ; Rose ML
J Leukoc Biol; 2008 Feb; 83(2):263-71. PubMed ID: 17974709
[TBL] [Abstract][Full Text] [Related]
22. Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells.
Camussi G; Pawlowski I; Bussolino F; Caldwell PR; Brentjens J; Andres G
J Immunol; 1983 Oct; 131(4):1802-7. PubMed ID: 6311899
[TBL] [Abstract][Full Text] [Related]
23. N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest.
Cakir O; Oruc A; Kaya S; Eren N; Yildiz F; Erdinc L
J Card Surg; 2004; 19(3):221-5. PubMed ID: 15151648
[TBL] [Abstract][Full Text] [Related]
24. [Effects of leukocyte depletion filter on canine kidney during cardiopulmonary bypass].
Yang YB; Zhu ZQ; Zheng H; Du L; Huang SM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):321-4. PubMed ID: 16045024
[TBL] [Abstract][Full Text] [Related]
25. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
[TBL] [Abstract][Full Text] [Related]
26. Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model.
Kim WG; Lee BH; Seo JW
Perfusion; 2001 May; 16(3):207-14. PubMed ID: 11419656
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
Carter MB; Wilson MA; Wead WB; Garrison RN
J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
[TBL] [Abstract][Full Text] [Related]
28. [Influence of pulmonary artery perfusion with solution of washed red blood cells on lung injury after cardiopulmonary bypass].
Song Y; Gong XJ; Gu XH; Li R; Zhang G; Zhang XQ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1421-4. PubMed ID: 16796928
[TBL] [Abstract][Full Text] [Related]
29. Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig.
Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Lauronen J; Paavonen T; Petäjä J
Acta Anaesthesiol Scand; 2007 Feb; 51(2):178-88. PubMed ID: 17096669
[TBL] [Abstract][Full Text] [Related]
30. Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients.
Massoudy P; Zahler S; Becker BF; Braun SL; Barankay A; Richter JA; Meisner H
Eur J Med Res; 1999 May; 4(5):178-82. PubMed ID: 10336406
[TBL] [Abstract][Full Text] [Related]
31. [The pulmonary protective effects of leukocyte depletion with a modified filter located at the cardiopulmonary bypass (CPB) venous line in canine].
Li Q; Chen HJ; Du L; Zhou L; Wang Y; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):723-6. PubMed ID: 16235549
[TBL] [Abstract][Full Text] [Related]
32. The role of platelet-activating factor in the pulmonary response to inhaled bacterial endotoxin.
Lantz RC; Keller GE; Burrell R
Am Rev Respir Dis; 1991 Jul; 144(1):167-72. PubMed ID: 2064124
[TBL] [Abstract][Full Text] [Related]
33. The roles of platelet-activating factor (PAF) in pulmonary vasoconstriction during venous air embolism in anesthetized mongrel dogs.
Ohno S; Suzuki N; Kitamura S
J Lipid Mediat; 1992; 5(2):187-9. PubMed ID: 1525361
[TBL] [Abstract][Full Text] [Related]
34. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
[TBL] [Abstract][Full Text] [Related]
35. Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response.
Siepe M; Goebel U; Mecklenburg A; Doenst T; Benk C; Stein P; Beyersdorf F; Loop T; Schlensak C
Ann Thorac Surg; 2008 Jul; 86(1):115-22. PubMed ID: 18573409
[TBL] [Abstract][Full Text] [Related]
36. Additional lung-protective perfusion techniques during cardiopulmonary bypass.
Suzuki T
Ann Thorac Cardiovasc Surg; 2010 Jun; 16(3):150-5. PubMed ID: 20930674
[TBL] [Abstract][Full Text] [Related]
37. Concentrated platelets harvesting before cardiopulmonary bypass improved cardiac and pulmonary function.
Kunitomo R; Kitamura N; Utoh J; Nishimura K; Sakaguchi H; Uemura S; Hagiwara S
J Cardiovasc Surg (Torino); 2002 Apr; 43(2):161-5. PubMed ID: 11887048
[TBL] [Abstract][Full Text] [Related]
38. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass.
Zehr KJ; Poston RS; Lee PC; Uthoff K; Kumar P; Cho PW; Gillinov AM; Redmond JM; Winkelstein JA; Herskowitz A
Ann Thorac Surg; 1995 Feb; 59(2):328-35. PubMed ID: 7847945
[TBL] [Abstract][Full Text] [Related]
39. Effect of prostacyclin PGI2 on cardiopulmonary bypass-induced lung injury.
Fessatidis IT; Brannan JJ; Taylor KM; Kanellaki-Kyparissi M; Abdulla AK; Olsen EC
Perfusion; 1994 Jan; 9(1):23-33. PubMed ID: 8161864
[TBL] [Abstract][Full Text] [Related]
40. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass.
Gu YJ; Wang YS; Chiang BY; Gao XD; Ye CX; Wildevuur CR
Ann Thorac Surg; 1991 Apr; 51(4):573-8. PubMed ID: 2012415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
